Summary.
Spot 35 protein is identical to rat brain calbindin, as based on the complete homology of their nucleotide sequence, and is named here as spot 35-calbindin.
The Spot 35 protein is a Ca-binding protein originally isolated from the soluble fraction of the rat cerebella and specifically localized in the Purkinje cells by immunohistochemistry (YOsHIDA and TAKAHASHI, 1980; YAMAKUNI et al., 1984 YAMAKUNI et al., , 1985 . The nucleotide sequence of cDNA encoding spot 35 protein has subsequently been determined as 1,714 base pairs including 783 base pairs of the complete coding region (YAMAKUNI et al., 1986 (YAMAKUNI et al., , 1987 . The amino acid sequence of the protein deduced from the nucleotide sequence contains 261 amino acid and at least five Ca-binding domains and a calculated molecular weight of 29,996. YAMAKUNI et al. (1987) have thus indicated a high homology in the amino acid sequences (79%) and the nucleotide sequences (77%) between spot 35 protein and 28 kD-vitamin Ddependent intestinal Ca-binding protein of chicks chick calbindin) (WASSERMAN and TAYLOR, 1966; VARGHESE et al., 1988; WOOD et al., 1988) . Furthermore, cDNA clones have recently been isolated from a rat brain library using the chick calbindin, and consequently spot 35 protein has been revealed to be identical to the rat brain calbindin because of the complete coincidence in the nucleotide and amino acid sequences (HUNZIKER and SCHRICKEL, 1988) . Therefore, we propose here to call spot 35 protein as spot 35-calbindin.
Since intracellular Ca is a key factor involved in many cellular activities such as exocytosis and signal transmission, and because Ca-binding proteins are presumed to be involved in controlling intracellular Ca concentration (CARAFOLI, 1987) , it is important to know the localization of calbindin in the endocrine organs as well as the nervous system. With this view point, the occurrence of immunoreactivity for spot 35-calbindin has been briefly reported in the anterior *This study was supported in part by a grant from Matsumura Clinic Foundation , Yamamotocho, Miyagi Prefecture, Japan. pituitary of dogs (HozuMI et al., 1986) . Considering the fact that the anterior pituitary consists of heterogenous populations of cells secreting discrete peptide hormones (KUROsUMI, 1968; NAKANE, 1970) , several quenstions should be answered for understanding the functional significance of calbindin, namely: which types of the endocrine cells exhibit calbindin, how the expression pattern of this protein is accomplished during the development of this organ, and whether the expression of this protein is changeable depending on the activity of individual endorine cells.
In this study, as a part of the search for the detailed localization of this Ca-binding protein outside the brain (KONDO et al., 1985 (KONDO et al., , 1988 YAMAMOTO et al., 1990) , we examined the anterior pituitary of rats by immunohistochemistry and clarified the morphological characteristics of cells immunoreactive for spot 35-calbindin to answer those questions listed above.
MATERIALS AND METHODS
Albino rats of both sexes used in the present study were at their embryonic Day 14, 16, 18 and 20, and postnatal Day 0, Week 3, 5, 7 and 10. Adult female rats (10 weeks) were used at each estrous cycle (at proestrus 12 : 00, estrus 2 : 00, metestrus 12 : 00, diestrus 12 : 00). Under Nembutal anesthesia (40 mg/kg b. w., intraperitoneally) the animals were perfused through the heart with 4% paraformaldehyde buffered at pH 7.3 by 0.1 M phosphate at 4'C . Thereafter younger fetuses or excised hypophysis from older fetuses and postnatal specimens were placed in the same fixative for 4 h at room temperature and subsequently transferred into 30% sucrose buffered at pH 7.3 by 0.1 M phosphate at 4t.
Specimens were frozen and 10-20 ,um thick sections were cut on a cryostat. The tissue sections were incubated with the rabbit anti-spot 35-calbindin antiserum at a dilution of 1:1000 or 1: 2000 for 12 h at room temperature.
The control serum was obtained by the addition of 10 ,ug of bovine spot 35 protein into 1 ml of the corresponding antiserum diluted at 1:1000. Detailed procedures for the isolation of spot 35-calbindin and the preparation and specificity of the antiserum have already been described elsewhere (YAMAKUNI et al., 1984; KoNDO et al., 1988) .
The tissue sections were placed in the biotinylated second antibody (anti-rabbit IgG) at a dilution of 1: 200 for 1 h and then in the peroxidase-conjugated Streptavidin (Dacopatts, Denmark) at a dilution of 1: 600 for 1 h. The sites of antigen-antibody reaction were made visible by DAB (3,3'-diaminobenzidine tetrahydrochloride) reaction. For immunoelectron microscopy, tissue sections were further postosmicated and embedded in Epon 812.
Antisera agaist anterior pituitary hormones were kindly supplied by The Institute of Endocrinology, Gunma University, Maebashi, Japan. Their optimal dilutions were as follows: the rabbit anti-porcine ACTH serum at a dilution of 1:40,000, the rabbit anti-rat GH serum at 1:10,000, the rabbit anti-ovine LH-/3 subunit serum at 1: 5,000, the rabbit anti-rat prolactin serum at 1:10,000, and the rabbit anti-rat thyrotropin serum at 1: 4,000.
RESULTS
On embryonic Day 16, a few cells immunoreactive for spot 35-calbindin were first detected solitarily in the anterior pituitary anlage (Fig, 1) . As the development proceeded, the immunoreactive cells gradually increased in number, with a slightly higher population density occupying the antero-ventral portion of the pars distalis and the pars tuberalis (Fig. 2) . No differences in number or distribution of the immunoreactive cells were noticed between the sexes until postnatal Week 3; the immunoreactive cells were still rather sparsely distributed in the main portion of the pars distalis at this age (Figs. 3, 4) .
At postnatal Week 5 and thereafter, spot 35-immunoreactive cells in the male anterior pituitary (Fig. 5) were much more numerous than in the female counterpart (Fig. 6) , although the immunoreactive cells in the anterior pituitary of the adult male rats comprised less than half of the total population of cells (Fig. 5) . The sex difference in number of the immunoreactive cells was especially evident in the main portion of the pars distalis. No immunoreactive cells were recognized in the marginal layer of the pars distalis in either sex. No difference in the population density was noted among female rats with different estrous conditions. By the immunolight microscopic mirror method, cells simultaneously immunoreactive for spot 35-calbindin and any one of the anterior pituitary hormones including ACTH, GH, LH-/3, PRL, TSH were consistently found in the adult specimens (Fig. 7) . However, the chance of detection of such cells simultaneously immunoreactive for either two chemical substances was rather sporadic, and it was therefore not possible with this method to identify which peptide hormones were contained in every cell immunoreactive for spot 35-calbindin. In immunoelectron microscopy of the adult anterior pituitary gland, all the spot 35-immunoreactive cells contained secretory granules in the cytoplasm, and folliculostellate cells characterized by prominent microvilli and absence of secretory granules were immunonegative for spot 35-calbindin. The immunoreactive material was localized in the cytoplasmic matrix except for the interior of membranous organelles such as mitochondria and endoplasmic reticulum (Fig. 8) .
Based on the ultrastructural morphology of the secretory granules, the spot 35-immunoreactive cells in the anterior pituitary gland in adult rats of both sexes were classified into four types. Type A cells contained round granules of almost uniform diameter about 350 nm and moderate electron density (Fig. 8a) . Type B cells contained larger (more than 350 nm), irregularly shaped granules with high electron density in addition to round granules similar to those of type A cells (Fig. 8b) . Type C cells were character- ized by round granules with uniformly small diameters up to 150 nm and moderate electron density (Fig.  8c) . Type D cells contained a mixture of the round, large and small granules (Fig. 8d) . The frequency of occurrence of the different cell types immunoreactive for spot 35-calbindin is summarized in Table 1 . In the adult male adenohypophysis type A cells were dominant, followed by type B, type D and type C cells, while type C cells were dominant and no type A cells were found in non-pregnant female specimens.
DISCUSSION
Three main findings should be pointed out from the present immunohistological study. First, immunoreactivity for spot 35-calbindin could be expressed in any of the five anterior pituitary hormone-producing cells. Second, spot 35-immunoreactivity was detected in the anterior pituitary anlage as early as the time when pituitary hormones become detectable in the course of development (WATANABE and DAIKOKU, 1979) . Third, the sexual difference in number of spot 35-immunoreactive cells was evident after postnatal Week 5 with a much higher population density in the male gland.
The marked increase in number of spot 35-immunoreactive cells in the male gland and resultant appearance of the sexual difference in their population density after postnatal Week 5 are largely synchronous with the establishment of the mature pattern in the composition of the sectretory granules of the endocrine cells (KUROSUMI et al., 1987; OZAWA and KUROSUMI, 1989) . This, together with the synchronous occurrence of spot 35-immunoreactivity with the immunoreactivity for the pituitary hormones in development (WATANABE and DAIKOKU, 1979; KUROSUMI and TOSAKA, 1988; KUROSUMI et al., 1989) , and the colocalization of spot 35-calbindin with any of the five anterior pituitary homones, implies the intimate involvement of the spot 35-calbindin in the activity of the anterior pituitary gland.
Antibodies agaist spot 35-calbindin and those against individual pituitary hormones raised in different animal species are not available at present. Moreover, chances for the detection of cells simultaneously immunoreactive for the twe discrete substances are sporadic with the present method using two adjacent sections. For these reasons, it is impossible to exactly identify the pituitary hormones contained in each cell immunoreactive for spot 35-calbindin and to quantitatively analyze the colocalization of spot 35-calbindin and pituitary hormones. However, the present analysis on the ultrastructure of the secretory granules suggests that the sexual difference in the population density of the spot 35-immunoreactive cells at the adult stage is mainly due to the difference in proportion of cells exhibiting round, large granules which correspond to GH-cells (GH type I) on the basis of the ultrastructural criteria of rat anterior pituitary (KUROSUMI et al., 1986) . This implies the difference in some Ca-related activities, including the secretion of GH-cells between both sexes. In addition, the frequent occurrence of cells containing small, round granules is another feature of the immunoreactive cell composition in the female pituitary as compared with the male counterpart. This cell type includes populations of ACTH-, TSH-, and PRL-cells; therefore, it is suggested that the sexual difference exists in the Ca-related activity of some, if not all, of ACTH-, TSH-and PRL-secreting cells, which probably represents the sexual difference in hormonal demands. Whether or not further fluctuation in the expression of spot 35-immunoreactivity occurs in any endocrine cells depending on their hormonal demands remains to be elucidated. REFERENCES CARAFOLI, E.: Intracellular calcium homeostasis. Ann. Rev. Biochem. 56: 395-433 (1987) . HozuMl, I., T. IWANAGA, T. FUJITA, T. YAMAKUNI and Y.
TAKAHASHI: A Purkinje cell-specific protein (spot 35 protein) showing wide distribution in the endocrine system of some mammals. An immunohistochemical study. Acta Histochem. Cytochem. 19: 545-553 (1986) . 
